Product Releases

Protective Disk Proven To Reduce Catheter-Related Infection

Fri, 05/08/2009 - 7:39am


The Wound Management division of Ethicon, Inc. offers the Biopatch, a protective disk with CHG to prevent catheter-related bloodstream infections (CRBSI) and local infections. According to the company, it is the only dressing clinically proven for use in skin antisepsis. A study published in JAMA® in 2009 showed use of a chlorhexidine gluconate-impregnated sponge (CHGIS) in intravascular catheter dressings reduced rates of catheter-related infections (CRIs), and also showed that changing unsoiled, adherent dressings every seven days rather than three days appears safe. Features of the Biopatch include:

  • A unique design to continually release CHG over 7 days, providing 360º protection
  • CHG, which has proven residual and cumulative effect on the skin and is proven effectiveness in the presence of organic matter including blood, sera and proteins


Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.